×

Introducing MSAA’s President and CEO, Amanda Montague 

The Multiple Sclerosis Association of America (MSAA) is extremely proud to announce the appointment of Amanda Montague, EdM, to the position of President and CEO! For more than 20 years, Ms. Montague has been a dynamic leader at MSAA, playing a vital … Continue reading → Source:…

MRI and disability scores better predict RRMS cognitive decline than blood tests

In stable relapsing-remitting multiple sclerosis (RRMS), higher physical disability scores and brain volume loss on MRI are stronger indicators of cognitive impairment than common blood biomarkers. A new study found that while blood tests often fail to reflect mental decline, MRI scans and standard disability…

Miniature brains grown in lab may help evaluate MS treatments

28bio has developed miniature brain models to help evaluate potential treatments that aim to repair myelin, the fatty coating around nerve fibers that is damaged in multiple sclerosis (MS) and other conditions. The CNS-3D Myelinated Organoids contain multiple brain cell types, including nerve cells and…

ChariotMS – an update

Tweet Some might say I’ve been a bit absent from this forum, and it’s true. However, plenty of work has been done by a team so large there wasn’t enough space on the latest abstract submission to MSToronto2026 to include even the most involved, since…

Maybe You’re Already Doing It… 

By Angel Blair I think it goes without saying how important one’s overall health is. Though when we talk about health and wellness, we often just think of the physical aspects. But a crucial part of our well-being relies on … Continue reading → Source:…

2 common MS treatments show equal benefit in late-onset disease

Two commonly used disease-modifying treatments seem to be equally effective for most people with late-onset multiple sclerosis (LOMS), according to a real-world analysis. Anti-CD20 therapies, designed to reduce immune cells that produce disease-driving antibodies, and S1P receptor modulators, which work by preventing pro-inflammatory immune cells from…

Barriers to Treatment

Tweet Surely number one is avoiding..idiot neuro Snider L, Rodriguez E, Rains H, Peraza H, Montalvo M, Rempe T. Factors associated with delays in multiple sclerosis disease-modifying therapy initiation. Mult Scler J Exp Transl Clin. 2026;12:20552173261447996. doi: 10.1177/20552173261447996. PMID: 42112096; PMCID: PMC13153518. Background: In multiple sclerosis…